✨ Medicines Consent Notices




25 OCTOBER

NEW ZEALAND GAZETTE

3641

Consent to the Distribution of a New Related Product

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:

Schedule

Product: Colgate Total plus Whitening Fluoride Toothpaste

Active Ingredient(s): Sodium fluoride 0.22%w/w equivalent to 1000ppm fluoride ion
Triclosan 0.3%w/w

Dosage Form: Toothpaste

New Zealand Sponsor: Colgate-Palmolive Limited

Manufacturer(s): Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia

Dated this 16th day of October 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7448

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:

Schedule

Product: Metalyse

Active Ingredient(s): Tenecteplase 30mg

Dosage Form: Powder for injection

New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited

Manufacturer(s): Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany

Product: Metalyse

Active Ingredient(s): Tenecteplase 40mg

Dosage Form: Powder for injection

New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited

Manufacturer(s): Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany

Product: Metalyse

Active Ingredient(s): Tenecteplase 50mg

Dosage Form: Powder for injection

New Zealand Sponsor: Boehringer Ingelheim (NZ) Limited

Manufacturer(s): Boehringer Ingelheim Pharma KG, Biberach an der Riss, Germany

Dated this 16th day of October 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7449

Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Stocrin

Active Ingredient(s): Efavirenz 300mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited

Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America

Note: This consent is valid for 2 years from the date of publication of this notice.

Product: Stocrin

Active Ingredient(s): Efavirenz 600mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited

Manufacturer(s): Du Pont Pharmaceuticals Company, Garden City, New York, United States of America

Note: This consent is valid for 2 years from the date of publication of this notice.

Dated this 16th day of October 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).

go7450



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 145


Gazette.govt.nz PDF NZ Gazette 2001, No 145





✨ LLM interpretation of page content

πŸ₯ Consent to Distribution of New Related Product

πŸ₯ Health & Social Welfare
16 October 2001
Medicines Act, New Related Product, Distribution Consent, Toothpaste, Colgate
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Consent to Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
16 October 2001
Medicines Act, Changed Medicines, Distribution Consent, Metalyse, Boehringer Ingelheim
  • G. R. Boyd, Chief Advisor, Safety and Regulation

πŸ₯ Provisional Consent to Distribution of New Medicine

πŸ₯ Health & Social Welfare
16 October 2001
Medicines Act, Provisional Consent, New Medicine, Stocrin, Merck Sharp & Dohme
  • G. R. Boyd, Chief Advisor, Safety and Regulation